Prevention or Modification of Varicella Using Zoster Immune Plasma

H. H. Balfour, K. E. Groth, J. McCullough, J. M. Kalis, S. C. Marker, M. E. Nesbit, R. L. Simmons, J. S. Najarian

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


Zoster immune plasma (ZIP) was given to 31 susceptible immunocompromised children one to seven days (median, two days) following household, playmate, or hospital exposures to varicella. The average amount of ZIP transfused was 7 ml/kg. Twenty-one children did not develop varicella or persistent antibodies to varicella-zoster virus (VZV). Eight (26%) of the 31 contracted clinical varicella. Seven cases were mild, but in one child, who was given ZIP seven days after exposure, visceral disease developed and the child died. Two children had subclinical varicella that was documented by persistence of VZV antibodies for at least ten months after passive immunization. Because none of the 30 children given ZIP one to six days following exposure had severe varicella, we conclude that ZIP is effective in preventing or modifying varicella in immunocompromised patients if given shortly after exposure.

Original languageEnglish (US)
Pages (from-to)693-696
Number of pages4
JournalAmerican Journal of Diseases of Children
Issue number6
StatePublished - Jun 1977


Dive into the research topics of 'Prevention or Modification of Varicella Using Zoster Immune Plasma'. Together they form a unique fingerprint.

Cite this